Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 1

Status

Unknown 3Terminated 1

Sponsor Class

NIH 4OTHER 3

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4

Conditions

Breast Neoplasms 39Carcinoma, Intraductal, Noninfiltrating 6Breast Carcinoma In Situ 5Inflammatory Breast Neoplasms 4Central Nervous System Neoplasms 3Liver Neoplasms 2Gliosarcoma 2Glioma 2Glioblastoma 2Fallopian Tube Neoplasms 2Carcinoma, Ovarian Epithelial 2Carcinoma, Hepatocellular 2Breast Neoplasms, Male 2Brain Neoplasms 2Astrocytoma 2Uveal Melanoma 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Sarcoma 1Recurrence 1Pheochromocytoma 1Ovarian Neoplasms 1Osteosarcoma 1Optic Nerve Glioma 1Oligodendroglioma 1Neoplasms 1Neoplasm Metastasis 1Mesothelioma, Malignant 1Melanoma 1

Interventions

Cyclophosphamide 10Docetaxel 6Trastuzumab 5Radiotherapy 5Tamoxifen 4Neoadjuvant Therapy 4Filgrastim 4Doxorubicin 4tipifarnib 3Peripheral Blood Stem Cell Transplantation 3Epirubicin 3Thiotepa 2Radiation 2Paclitaxel 2Fluorouracil 2Chemotherapy, Adjuvant 2Carboplatin 2Capecitabine 2Bevacizumab 2pegfilgrastim 1olaparib 1cediranib 1aldesleukin 1Therapeutics 1Taxes 1Specimen Handling 1Razoxane 1Methotrexate 1Mesna 1Interleukin-12 Subunit p35 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
NIH × Inflammatory Breast Neoplasms × Tamoxifen × Clear all
NCT00003679 2013-11-06

Combination Chemotherapy in Treating Women With Breast Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
350 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00003680 2013-11-06

Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
300 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00016276 2013-01-16

Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer

National Cancer Institute (NCI)

Phase 3 Terminated
396 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms, Cardiotoxicity

NCT00398489 2010-11-09

Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery

National Cancer Institute (NCI)

Phase 2 Unknown
94 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡